The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | Genomic variants in Eastern and Western patients with WM
Shuhua Yi, MD, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China, discusses differences in the incidence of Waldenström’s macroglobulinemia (WM) in Eastern and Western populations, and possible explanations for this. Dr Yi shares some insights into a study which used next-generation sequencing (NGS) techniques to analyze various cytogenetic aberrations in patients, and explains the differences observed between the two populations. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
